Nova Leap Health (NLH) AI Stock Analysis

• Market Cap: C$29.69M
• Dividend Yield: N/A
• Average Volume (3M): 21.45K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.54
• Revenue Growth: 19.61%
• EPS Growth: N/A
• Country: CA
• Employees: 541
• Sector: General
• Sector Strength: N/A
• Industry: Medical - Care Facilities
• EPS (TTM): >-0.01
• Shares Outstanding: 87,314,255
• 10 Day Avg. Volume: 17,344
• 30 Day Avg. Volume: 21,452
• PEG Ratio: 0.81
• Price to Book (P/B): 0.94
• Price to Sales (P/S): 0.56
• P/FCF Ratio: 12.58
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 63 Neutral
• Price Target: C$0.33 ▲(17.86% Upside)
• Action: Reiterated Date: 03/07/26
• Date: Action: Reiterated 03/07/26

The score is driven primarily by mixed financial performance—stronger solvency and positive (but softening) cash generation offset by volatile profitability and a 2025 net loss. Technicals add support as the stock is trading above key moving averages with positive MACD. Valuation is a headwind because earnings are negative (P/E not meaningful) and no dividend yield is available.

Positive Factors

Conservative Balance Sheet

A low debt-to-equity (~0.15 in 2025) gives durable financial flexibility, lowering distress risk and supporting capital allocation for local agency operations and targeted investments. Conservatism in leverage helps sustain operations through reimbursement or seasonal demand cycles.

Negative Factors

Profitability Volatility

Earnings instability and compressed operating margins reduce the firm's ability to reliably fund growth and absorb integration costs. A return to a net loss in 2025 signals fragile operating leverage, making medium-term profitability recovery uncertain without structural cost or revenue improvements.

Nova Leap Health Business Overview & Revenue Model

Company Description

Nova Leap Health Corp. provides home and home health care services in the United States and Canada. Its services include dementia care, companionship, personal and respite care, cooking and meal preparation, bathing, dressing, grooming, housekeepi...

Read more

Nova Leap Health Corp. provides home and home health care services in the United States and Canada. Its services include dementia care, companionship, personal and respite care, cooking and meal preparation, bathing, dressing, grooming, housekeepi...

How the Company Makes Money

NLH makes money by generating service revenue from delivering home care visits and ongoing in-home support to clients. Its core revenue stream is fees paid for non-medical home care services (typically billed by the hour or by service package) del...

Read more

NLH makes money by generating service revenue from delivering home care visits and ongoing in-home support to clients. Its core revenue stream is fees paid for non-medical home care services (typically billed by the hour or by service package) del...

Nova Leap Health Financial Statement Overview

Breakdown	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	32.02M	25.76M	26.18M	28.21M	21.28M
Gross Profit	11.85M	9.89M	9.77M	9.98M	7.21M
EBITDA	1.97M	2.50M	994.47K	420.35K	4.76M
Net Income	-193.19K	1.38M	-1.05M	-835.75K	1.76M
Balance Sheet
Total Assets	23.44M	22.39M	20.90M	23.95M	26.77M
Cash, Cash Equivalents and Short-Term Investments	1.49M	1.40M	894.76K	1.27M	1.73M
Total Debt	2.93M	2.53M	1.40M	3.97M	6.20M
Total Liabilities	4.43M	4.14M	2.70M	5.27M	8.29M
Stockholders Equity	19.01M	18.25M	18.20M	18.68M	18.48M
Cash Flow
Free Cash Flow	1.42M	1.36M	2.13M	949.49K	2.18M
Operating Cash Flow	1.42M	1.39M	2.15M	1.02M	2.18M
Investing Cash Flow	-1.26M	-1.59M	-23.13K	-56.24K	-7.40M
Financing Cash Flow	-86.91K	729.78K	-2.52M	-1.41M	4.33M

Nova Leap Health Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.28
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:NLH, the sentiment is Positive. The current price of 0.28 is below the 20-day moving average (MA) of 0.33, below the 50-day MA of 0.32, and below the 200-day MA of 0.30, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 54.46 is Neutral, neither overbought nor oversold. The STOCH value of 91.67 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:NLH.

Nova Leap Health Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
EXE	70 Outperform	C$2.72B	18.86	47.65%	2.28%	11.59%	41.99%
DR	67 Neutral	C$298.35M	10.68	89.16%	2.35%	-40.05%	558.77%
CRRX	66 Neutral	C$227.25M	9.17	28.24%	1.03%	0.19%	―
NLH	63 Neutral	C$29.69M	-92.15	4.10%	―	19.61%	―
SIA	63 Neutral	C$2.26B	42.05	6.93%	4.47%	11.47%	6.45%
Sector *	55 Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
PHA	46 Neutral	C$1.11M	-0.14	202.02%	―	-22.61%	7.72%

Nova Leap Health Corporate Events